Page last updated: 2024-09-05

dexefaroxan and amphetamine

dexefaroxan has been researched along with amphetamine in 1 studies

Compound Research Comparison

Studies
(dexefaroxan)
Trials
(dexefaroxan)
Recent Studies (post-2010)
(dexefaroxan)
Studies
(amphetamine)
Trials
(amphetamine)
Recent Studies (post-2010) (amphetamine)
150413,0713291,977

Protein Interaction Comparison

ProteinTaxonomydexefaroxan (IC50)amphetamine (IC50)
Phenylethanolamine N-methyltransferaseBos taurus (cattle)0.96
Cytochrome P450 2A6Homo sapiens (human)3.5
Cytochrome P450 2A5Mus musculus (house mouse)2.85
Sodium-dependent dopamine transporterRattus norvegicus (Norway rat)0.96
Beta-2 adrenergic receptorCavia porcellus (domestic guinea pig)0.96

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bizot, JC; Colpaërt, F; Drouin, C; Glowinski, J; Marien, M; Tassin, JP; Villégier, AS1

Other Studies

1 other study(ies) available for dexefaroxan and amphetamine

ArticleYear
Stimulation of postsynaptic alpha1b- and alpha2-adrenergic receptors amplifies dopamine-mediated locomotor activity in both rats and mice.
    Synapse (New York, N.Y.), 2003, Dec-15, Volume: 50, Issue:4

    Topics: Adrenergic Agents; Amphetamine; Animals; Behavior, Animal; Benzopyrans; Cerebellum; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Hyperkinesis; Imidazoles; Locomotion; Male; Mice; Mice, Knockout; Oxidopamine; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Time Factors

2003